Mar 27, 2023 · EQS-News: Grünenthal GmbH / Key word(s): Annual ResultsGrünenthal GmbH: Grünenthal reports record revenue and profit in 2022 full-year results and strong pipeline progress …

Annual Report 2024/25 In 2024, Grünenthal continued to invest in innovative pain medicines with the power to drive future growth. In our latest report, we share the latest insights into our company’s …

Mar 25, 2024 · EQS-News: Grünenthal GmbH / Key word(s): Annual ResultsGrünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions …

Mar 27, 2025 · EQS-News: Grünenthal GmbH / Key word(s): Annual ResultsGrünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US …

Mar 25, 2024 · Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions In 2023, Grünenthal generated €1.8 billion in revenues, an increase of 10 …

Unsere Liste der Unternehmenspublikationen enthält den Nachhaltigkeitsbericht, den Verhaltenskodex sowie weitere geschäftsbezogene Materialien.

the annual report and consolidated financial statements for the Issuer group; and information relating to the Notes and/or wider Issuer group.

Gaining further financial flexibility and investing in future growth Investments included measures to strengthen our business with QutenzaTM in the US. We see significant opportuni-ties for further …

Dec 6, 2024 · Grünenthal GmbH, Aachen, Germany, District Court of Aachen HRB 3546: Revenue, Public funding, Earnings, Employees, Network, Financial information

Grünenthal reports 2021 full-year results of €1.5 billion in net revenues with double-digit growth and major investments in portfolio and pipeline.

Grünenthal’s 2019/20 annual report shares insights into our record-breaking year Grünenthal achieved the best ever financial performance in 2019 with EBITDA growth exceeding 60 percent – and took …

Mar 25, 2024 · [1]Based on internal analysis by Grünenthal GmbH using data from IQVIA Forecast Link Q3 2023 release forecast data, with historical data up to and including Q3 2023 and forecast data for …

Strategy for growth Grünenthal’s portfolio of established medicines has outper-formed its respective markets. Since 2017, we have invested more than €2 billion in successful acquisitions of established …

Use our commercial database of more than 120 million business records & industry directory for company research & industry analysis. Start sales research here.